These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27383922)

  • 61. Feasibility and efficacy of a multidisciplinary palliative approach in patients with advanced interstitial lung disease. A pilot randomised controlled trial.
    Bassi I; Guerrieri A; Carpano M; Gardini A; Prediletto I; Polastri M; Curtis JR; Nava S
    Pulmonology; 2023 Dec; 29 Suppl 4():S54-S62. PubMed ID: 34969647
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Physical activity, exercise capacity and mortality risk in people with interstitial lung disease: A systematic review and meta-analysis.
    Rocha V; Paixão C; Marques A
    J Sci Med Sport; 2022 Nov; 25(11):903-910. PubMed ID: 36270901
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Oxygen in interstitial lung diseases.
    Cordeiro R; Nunes A; Smith O; Renzoni EA
    Breathe (Sheff); 2023 Mar; 19(1):220271. PubMed ID: 37378062
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A Phase-2 Exploratory Randomized Controlled Trial of INOpulse in Patients with Fibrotic Interstitial Lung Disease Requiring Oxygen.
    King CS; Flaherty KR; Glassberg MK; Lancaster L; Raghu G; Swigris JJ; Argula RG; Dudenhofer RA; Ettinger NA; Feldman J; Johri S; Fernandes P; Parsley E; Shah PS; Nathan SD
    Ann Am Thorac Soc; 2022 Apr; 19(4):594-602. PubMed ID: 34678128
    [No Abstract]   [Full Text] [Related]  

  • 65. Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis.
    Uronis HE; Currow DC; McCrory DC; Samsa GP; Abernethy AP
    Br J Cancer; 2008 Jan; 98(2):294-9. PubMed ID: 18182991
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ergogenic Value of Oxygen Supplementation in Patients with Idiopathic Pulmonary Fibrosis with Isolated Exertional Oxygen Desaturation.
    Vogiatzis I; Bouros D
    Respiration; 2021; 100(6):461-462. PubMed ID: 33849033
    [No Abstract]   [Full Text] [Related]  

  • 67. Barriers to and facilitators of the use of oxygen therapy in people living with an interstitial lung disease: a systematic review of qualitative evidence.
    Tikellis G; Hoffman M; Mellerick C; Burge AT; Holland AE
    Eur Respir Rev; 2023 Sep; 32(169):. PubMed ID: 37611946
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases.
    Kawano-Dourado L; Kulkarni T; Ryerson CJ; Rivera-Ortega P; Baldi BG; Chaudhuri N; Funke-Chambour M; Hoffmann-Vold AM; Johannson KA; Khor YH; Montesi SB; Piccari L; Prosch H; Molina-Molina M; Sellares Torres J; Bauer-Ventura I; Rajan S; Jacob J; Richards D; Spencer LG; Wendelberger B; Jensen T; Quintana M; Kreuter M; Gordon AC; Martinez FJ; Kaminski N; Cornelius V; Lewis R; Adams W; Jenkins G;
    Thorax; 2024 Jul; 79(8):788-795. PubMed ID: 38448221
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cardiovascular and Respiratory Interactions in Idiopathic Pulmonary Fibrosis by Extended Partial Directed Coherence: Short-term Effects of Supplemental Oxygen.
    Santiago-Fuentes LM; Charleston-Villalobos S; Gonzalez-Camarena R; Voss A; Mejia-Avila ME; Buendia-Roldan I; Reulecke S; Aljama-Corrales T
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():5446-5449. PubMed ID: 34892358
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Self-management of oxygen and bronchodilators to relieve the dyspnoea of lung cancer with pneumoconiosis.
    Kim JW; Park EY
    Int J Palliat Nurs; 2020 Apr; 26(4):167-174. PubMed ID: 32378485
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Not Available].
    Sørensen SR; Bendstrup E; Davidsen JR
    Ugeskr Laeger; 2022 Nov; 184(46):. PubMed ID: 36426814
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Exercise-Based Pulmonary Rehabilitation for Interstitial Lung Diseases: A Review of Components, Prescription, Efficacy, and Safety.
    Mendes RG; Castello-Simões V; Trimer R; Garcia-Araújo AS; Gonçalves Da Silva AL; Dixit S; Di Lorenzo VAP; Archiza B; Borghi-Silva A
    Front Rehabil Sci; 2021; 2():744102. PubMed ID: 36188788
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A scoping review of palliative care outcome measures in interstitial lung disease.
    Gersten RA; Moale AC; Seth B; Vick JB; Brown H; Eakin MN; Mathai SC; Danoff SK
    Eur Respir Rev; 2021 Sep; 30(161):. PubMed ID: 34348982
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Attenuation of exertional desaturation and preference for interval exercise compared to continuous exercise in people with interstitial lung disease.
    Dowman LM; May AK; Cox NS; Morris NR; Nakazawa A; Parker L; Bondarenko J; Holland AE
    Respirology; 2021 Nov; 26(11):1076-1079. PubMed ID: 34596934
    [No Abstract]   [Full Text] [Related]  

  • 75. A Retrospective, Descriptive Study of Dyspnea Management in a Multidisciplinary Interstitial Lung Disease Clinic.
    van den Bosch L; Wang T; Bakal JA; Richman-Eisenstat J; Kalluri M
    Am J Hosp Palliat Care; 2023 Feb; 40(2):153-163. PubMed ID: 35484838
    [No Abstract]   [Full Text] [Related]  

  • 76. WITHDRAWN: Oxygen therapy for dyspnoea in adults.
    Cranston JM; Crockett A; Currow D; Ekström M
    Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD004769. PubMed ID: 24259054
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Current Landscape and Future Directions of Patient Education in Adults with Interstitial Lung Disease.
    Savvaides TM; Demetres MR; Aronson KI
    ATS Sch; 2024 Mar; 5(1):184-205. PubMed ID: 38633514
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chronic breathlessness in fibrotic interstitial lung diseases-patient centered assessment and management in outpatient settings.
    Kalluri M
    Ann Palliat Med; 2024 Jul; 13(4):1056-1075. PubMed ID: 39043562
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Oxygen Therapy during Exercise in Patients with Interstitial Lung Diseases.
    Viani M; Ventura V; Bianchi F; d'Alessandro M; Bergantini L; Sestini P; Bargagli E
    Biomolecules; 2022 May; 12(5):. PubMed ID: 35625645
    [No Abstract]   [Full Text] [Related]  

  • 80. [Increasing dyspnoea and intermittent joint suffering].
    Lehnert NM; Behr J; Tufman A; Briegel I; Dinkel J
    Pneumologie; 2023 Oct; 77(10):825-829. PubMed ID: 36958340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.